P866: CORRELATIVE ANALYSIS TO DEFINE PATIENT PROFILES ASSOCIATED WITH MANUFACTURING AND CLINICAL ENDPOINTS IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IDECABTAGENE VICLEUCEL (BB2121)
J. Rytlewski,
J. Fuller,
D. R. Mertz,
C. Freeman,
S. Manier,
N. Shah,
T. B. Campbell
Affiliations
J. Rytlewski
1 Bristol Myers Squibb, Princeton, NJ
J. Fuller
1 Bristol Myers Squibb, Princeton, NJ
D. R. Mertz
1 Bristol Myers Squibb, Princeton, NJ
C. Freeman
2 Moffitt Cancer Center, Tampa, FL, United States of America
S. Manier
3 CHU de Lille, University of Lille, Lille, France
N. Shah
4 University of California San Francisco, San Francisco, CA, United States of America
